• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Search Results for: patent

El Patent Pool estimula las perspectivas de medicamentos anti-VIH con una primera Licencia

13/07/2011 by William New, Intellectual Property Watch 3 Comments

El Medicines Patent Pool y la compañía farmacéutica Gilead Sciences ha anunciado hoy un acuerdo de licencia para permitir la producción medicamentos clave para el combate contra el VIH a un menor costo y en una formulación más fácil de usar, haciéndolos más accesibles a los países en desarrollo.. El acuerdo se extiende al uso de tratamientos para la hepatitis B por primera vez.

Filed Under: IP Policies, Language, Themes, Venues, Biodiversity/Genetic Resources/Biotech, Development, Español, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, United Nations - other

Medicines Patent Pool Boosts HIV Drug Prospects With First Licence

12/07/2011 by William New, Intellectual Property Watch 4 Comments

The Medicines Patent Pool and pharmaceutical company Gilead Sciences today announced a breakthrough licence agreement to allow for the production of key HIV medicines at lower cost and in an easier-to-use formulation, making them more accessible to developing countries. The agreement also opens up the use of treatments for Hepatitis B for the first time.

Filed Under: IP Policies, Language, Themes, Venues, Development, English, Finance, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

Spain, Italy File Opposition To EU Unitary Patent

07/07/2011 by Intellectual Property Watch 2 Comments

The governments of Spain and Italy have filed complaints with the European Court of Justice calling for the annullment of a March European Council decision to create an EU unitary patent.

Filed Under: IP-Watch Briefs, IP Policies, Language, Venues, English, Europe, Patents/Designs/Trade Secrets

Special Report: A Quick Summary Of The New US Supreme Court Decisions On Patents

24/06/2011 by Steven Seidenberg for Intellectual Property Watch Leave a Comment

For the past ten years, the United States Supreme Court has steadily chipped away at patent rights. But this term, the court abruptly reversed direction. In two weeks, the high court issued rulings in three patent cases, and in every one upheld the legal rights of inventors. It is unclear, however, how big a win this really was for patent rights.

Filed Under: Features, IP Policies, Subscribers, Themes, Venues, Biodiversity/Genetic Resources/Biotech, Enforcement, English, Health & IP, IP Law, Innovation/ R&D, North America, Patents/Designs/Trade Secrets

US Patent Reform Advances Furthest In Congress In 10 Years

24/06/2011 by Liza Porteus Viana, Intellectual Property Watch 1 Comment

The US House of Representatives this evening passed HR 1249 – the closest action patent reform has come to being enacted into law in the past 10 years. But there were some changes made to the bill.

Filed Under: IP Policies, News, Subscribers, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Environment, Finance, Health & IP, Innovation/ R&D, North America, Patents/Designs/Trade Secrets

Patent Reform Debate: Live Updates From The US House Of Representatives

22/06/2011 by Liza Porteus Viana, Intellectual Property Watch Leave a Comment

Intellectual Property Watch is providing play-by-play action from today’s floor debate of HR 1249, the bill to reform US patent law which is facing a fight. For IP-Watch Subscribers.

Filed Under: IP Policies, Language, News, Subscribers, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Innovation/ R&D, North America, Patents/Designs/Trade Secrets

‘Long Overdue’ US Patent Reform Deal Reached; House Could Vote This Week

22/06/2011 by Liza Porteus Viana, Intellectual Property Watch Leave a Comment

US lawmakers this evening agreed to a manager’s amendment to the pending patent reform bill. The legislation could come to the floor of the House of Representatives for a vote as soon as tomorrow (22 June). The Senate version, S. 23, was passed in March.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Biodiversity/Genetic Resources/Biotech, English, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, WIPO

Outgoing US Commerce Chief Backs House Patent Reform Bill, Nearly

31/05/2011 by William New, Intellectual Property Watch Leave a Comment

Outgoing United States Commerce Secretary Gary Locke today gave near-complete approval of legislation to reform US patent law which is awaiting action in the House of Representatives.

Filed Under: IP Policies, Subscribers, Themes, Venues, English, IP Law, Innovation/ R&D, North America, Patents/Designs/Trade Secrets

WIPO Patent Law Committee: New Health Proposal, Tech Transfer Tensions

19/05/2011 by William New, Intellectual Property Watch 1 Comment

World Intellectual Property Organization members this week are engaged in substantive discussions on patent policy, including a first look at a developing country proposal on public health, a surprising debate over technology transfer, and details of a questionnaire on exceptions and limitations to patents. Also responses to first feedback on a new proposal on patent quality are expected to emerge shortly.

Filed Under: IP Policies, Language, News, Subscribers, Themes, Venues, Biodiversity/Genetic Resources/Biotech, Development, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, WIPO

Bill Gates Calls For “Vaccine Decade;” Explains How Patent System Drives Public Health Aid

17/05/2011 by William New and Catherine Saez, Intellectual Property Watch 3 Comments

Microsoft legend Bill Gates is impassioned about helping to save lives as head of a large-scale foundation. Today, he explained to Intellectual Property Watch how intellectual property rights help drive that process forward and make it sustainable.

Filed Under: IP Policies, Subscribers, Themes, Venues, Biodiversity/Genetic Resources/Biotech, Development, English, Finance, Health & IP, Human Rights, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHO

  • « Previous Page
  • 1
  • …
  • 51
  • 52
  • 53
  • 54
  • 55
  • …
  • 347
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2026 · Global Policy Reporting